These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2272037)

  • 1. Platinum compounds with estrogen receptor affinity.
    Bednarski PJ; Gust R; Spruss T; Knebel N; Otto A; Farbel M; Koop R; Holler E; von Angerer E; Schönenberger H
    Cancer Treat Rev; 1990 Sep; 17(2-3):221-31. PubMed ID: 2272037
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogens, phytoestrogens, and breast cancer.
    Clarke R; Hilakivi-Clarke L; Cho E; James MR; Leonessa F
    Adv Exp Med Biol; 1996; 401():63-85. PubMed ID: 8886127
    [No Abstract]   [Full Text] [Related]  

  • 3. A dichotomy in the lipophilicity of natural estrogens, xenoestrogens, and phytoestrogens.
    Cunningham AR; Klopman G; Rosenkranz HS
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):665-8. PubMed ID: 9168011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
    Rorke EA; Katzenellenbogen BS
    Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
    [No Abstract]   [Full Text] [Related]  

  • 5. Benzo[a]carbazole derivatives. Synthesis, estrogen receptor binding affinities, and mammary tumor inhibiting activity.
    von Angerer E; Prekajac J
    J Med Chem; 1986 Mar; 29(3):380-6. PubMed ID: 3950918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen platinum-diamine complexes: preparation of a non-steroidal estrogen platinum-diamine complex labeled with platinum-191 and a study of its binding to the estrogen receptor in vitro and its tissue distribution in vivo.
    DiZio JP; Carlson KE; Bannochie CJ; Welch MJ; Von Angerer E; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 1992 May; 42(3-4):363-73. PubMed ID: 1606047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity.
    Schneider MR
    J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oestrogen action in experimental breast cancer.
    Jordan VC; Naylor KE; Dix CJ; Prestwich G
    Recent Results Cancer Res; 1980; 71():30-44. PubMed ID: 6768113
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens.
    Hartmann RW
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():155-61. PubMed ID: 6329512
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of new drugs for endocrine tumour chemotherapy.
    von Angerer E
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():147-53. PubMed ID: 6547370
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas.
    Rose DP; Fischer AH; Jordan VC
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):893-8. PubMed ID: 7198978
    [No Abstract]   [Full Text] [Related]  

  • 12. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Verdeal K; Brown RR; Richardson T; Ryan DS
    J Natl Cancer Inst; 1980 Feb; 64(2):285-90. PubMed ID: 6766510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptors in breast tumors--current status.
    McGuire WL; Zava DT; Horwitz KB; Chamness GC
    Curr Top Exp Endocrinol; 1978; 3():93-129. PubMed ID: 350504
    [No Abstract]   [Full Text] [Related]  

  • 14. 2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity.
    Biberger C; von Angerer E
    J Steroid Biochem Mol Biol; 1996 Apr; 58(1):31-43. PubMed ID: 8809184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
    Hagen ML; Hellmers M; Abrahamsen B; Hagen C
    Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
    [No Abstract]   [Full Text] [Related]  

  • 16. Catechol estrogens of the 1,1,2-triphenylbut-1-ene type: relationship between structure, estradiol receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activities.
    Schneider MR; Ball H; Schiller CD
    J Med Chem; 1986 Aug; 29(8):1355-62. PubMed ID: 3016262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of estrogen and antiestrogen action in mammary cancer.
    Katzenellenbogen BS; Rorke EA; Eckert RL
    J Steroid Biochem; 1981 Dec; 15():219-29. PubMed ID: 7339248
    [No Abstract]   [Full Text] [Related]  

  • 18. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines.
    Lewis JB; Lapp CA; Schafer TE; Wataha JC; Randol TM; Schuster GS
    In Vitro Cell Dev Biol Anim; 2000 May; 36(5):320-6. PubMed ID: 10937835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.